SSA
APEN

Schonfeld Strategic Advisors’s Apollo Endosurgery, Inc. APEN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,739,807
Closed -$17.3M – 2721
2023
Q1 		$17.3M Buy
1,739,807
+1,712,876
+6,360% +$17M 0.17% 176
2022
Q4 		$269K Buy
+26,931
New +$201K ﹤0.01% 1849

Schonfeld Strategic Advisors's APEN Position: Q2 2023 in Review

Schonfeld Strategic Advisors sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 1,739,807 shares — an estimated $17.3M sold.

Schonfeld Strategic Advisors first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $17.3M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Schonfeld Strategic Advisors reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 1,739,807 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $17.3M.
  • Schonfeld Strategic Advisors first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Apollo Endosurgery, Inc. position peaked at $17.3M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.